Company detailsAltos Labs

Altos Labs

LongevityCellular ReprogrammingCell Rejuvenation
#91
NorgardX
Top 100

Illustrative curve — no price history on file for this company.

Express Investment Interest — coming to iOSPrivate, non-binding · Reviewed by NorgardX Capital Market

Funding

Raised a $3B round on Jan 19, 2022, bringing the total raised amount to $3B.

Hiring Signal

22Open roles
Altos Headquarters
2
Belmonte Lab
1
Discovery Science
6
Drug Discovery & Development Science
6
Institute of Computation
2
Institute of Technology
2

Based on public job postings · updated monthly

Latest news

Public companies tied to Altos Labs

About Altos Labs

Altos Labs is a biotechnology company pioneering cellular rejuvenation programming, using partial epigenetic reprogramming with Yamanaka factors to restore cell health and resilience and reverse disease, injury, and the disabilities of aging. It launched publicly in January 2022 with about $3 billion in initial funding, one of the largest biotech launches ever, backed by Jeff Bezos and Yuri Milner and led by CEO Hal Barron, with Nobel laureate Shinya Yamanaka as senior scientific advisor. The company remains privately held and its valuation is not officially disclosed; secondary-market estimates put it around $6 billion in early 2026.

Altos Labs on video

Founders

Hal Barron

Hal Barron

CEO & Founder

Physician-scientist and former Chief Scientific Officer and President of R&D at GSK; earlier led R&D at Alphabet's Calico and was CMO of Roche/Genentech. He became Altos Labs' founding CEO in 2022.

Hans Bishop

Hans Bishop

President & Founder

Veteran biotech executive who was founding CEO of Juno Therapeutics and CEO of GRAIL before co-founding Altos Labs as President.

Rick Klausner

Rick Klausner

Founder & Chief Scientific Advisor

Former director of the U.S. National Cancer Institute and serial biotech founder (Juno, GRAIL, Lyell) who serves as Altos Labs' Chief Scientific Advisor.

Key leaders

HV

Hal V. Barron

CEO, Founder and Board Co-Chair

Former GSK President of R&D and CSO; now CEO and Founder/Board Co‑Chair of Altos Labs.

Richard (Rick) Klausner

Richard (Rick) Klausner

Co-Founder, Chief Scientist, Co-Chair

Biotech entrepreneur and former director of the U.S. National Cancer Institute; Founder and Chief Scientist at Altos Labs.

KS

Kevin Sin

Chief Financial and Business Officer

Former GSK and Calico executive; now Chief Financial and Business Officer at Altos Labs.

JM

Joan Mannick, M.D.

SVP, Chief Medical Officer and Head of Product Development

Physician and biotech R&D leader; Chief Medical Officer and Head of Product Development at Altos Labs.

CW

Connie White

Chief People Officer

Human resources leader; serves as Chief People Officer at Altos Labs.

DW

David Williamson

Senior Vice President of Finance and Procurement

Senior finance and operations executive; Senior Vice President, Finance, Procurement, and Global Facilities at Altos Labs.

Recent hires